Novo Nordisk Subject to Ozempic Injury Lawsuit in Louisiana

Danish companies Novo Nordisk AS and Novo Nordisk North America Operations AS are subject to a Louisiana woman’s Ozempic injury suit in that state, a federal judge said.

The companies’ connections to Louisiana are sufficient and linked closely enough to plaintiff Jaclyn Bjorklund’s claims to support jurisdiction, Judge James D. Cain Jr. of the the US District Court for the Western District of Louisiana said Thursday.

Bjorklund alleges she was harmed by Ozempic and a similar Eli Lilly & Co. drug, Mounjaro. She says she suffered extreme vomiting, including bouts so severe that she lost teeth.

Ozempic and Mounjaro are ...